SELLAS Life Sciences Group, Inc. (SLS) vs Vera Therapeutics, Inc. (VERA)
A side-by-side comparison of SELLAS Life Sciences Group, Inc. and Vera Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
SLS
SELLAS Life Sciences Group, Inc.
$11.43HealthcareDelayed quote: Oct 6, 2026, 3:15 PM EDT
VERA
Vera Therapeutics, Inc.
$29.00HealthcareDelayed quote: Oct 6, 2026, 3:15 PM EDT
Total return — SLS vs VERA
growth of $100 · dividends reinvested · last 5ySLS +47.4% (+8.1%/yr)VERA +159.4% (+21.0%/yr)VERA compounded faster over this window
SLS VERA
SLS vs VERA: by the numbers
- •SLS is the larger company ($2.13B vs $2.08B market cap).
Metrics side by side
Valuation
| Metric | SLS | VERA |
|---|---|---|
| P/B ratio | 15.44 | 5.11 |
Profitability
| Metric | SLS | VERA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -23.58% | -98.56% |
| ROIC | -25.45% | -85.78% |
Growth (annualized)
| Metric | SLS | VERA |
|---|---|---|
| Total return CAGR (5Y) | 6.20% | 14.09% |
Frequently asked
- How have SLS and VERA total returns compared?
- Over the past 5 years, SLS delivered 6.20% and VERA delivered 14.09% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.